Two phase II trials - one in a population with obesity (without T2D) [45], and a second in a population with T2D and overweight/obesity [46], have recently been published and their key findings are presented below (Table 1)
Shima Hadidchi, MD , offers effective obesity treatment with Ozempic
If your BCBS affiliate currently covers Zepbound, there is no guarantee that coverage will persist into 2027 check your plan documents at each renewal period
Sermorelin is administered via subcutaneous injection, typically before bedtime
However, increasing the levels of glutathione may give numerous health benefits
Alexandra Sowa, recently joined the Plus SideZ podcast to answer the questions her patients ask most from why nausea hits so hard to what's actually driving metabolic dysfunction in the first place